These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4352751)

  • 21. Immunochemical characteristics of hamster antibodies reacting in complement-fixation with polyoma virus-induced tumour antigen.
    Ptak W; Zembala M; Porwit-Bobr Z
    Z Immunitatsforsch Allerg Klin Immunol; 1970 May; 139(4):340-6. PubMed ID: 4315805
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunologically privileged sites in studies of polyoma tumor antigens.
    HABEL K; BELCHER JH
    Proc Soc Exp Biol Med; 1963 May; 113():148-52. PubMed ID: 13951625
    [No Abstract]   [Full Text] [Related]  

  • 23. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [On the transplantability of tumors induced by the BB/T2-polyoma-virus strain].
    Gimmy J; Graffi A
    Arch Geschwulstforsch; 1963; 20(1):1-21. PubMed ID: 4284106
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of metabolic inhibitors on killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1411-3. PubMed ID: 4372384
    [No Abstract]   [Full Text] [Related]  

  • 26. COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. 8. ON THE DIFFERENT NATURE OF "ANTIBODY COFACTOR" AND COMPLEMENT.
    STYK B; KOCISKOVA D; HANA L
    Acta Virol; 1964 Nov; 8():496-506. PubMed ID: 14242988
    [No Abstract]   [Full Text] [Related]  

  • 27. Interrupting the early region of polyoma virus DNA enhances tumorigenicity.
    Israel MA; Simmons DT; Hourihan SL; Rowe WP; Martin MA
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3713-6. PubMed ID: 226975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to polyoma tumor cells in mice. I. Magnitude and specificity of the in vitro cellular cytotoxicity elicited by immunization with graded numbers of tumor cells.
    Walia AS; Lamon EW
    J Natl Cancer Inst; 1977 Jun; 58(6):1671-5. PubMed ID: 194042
    [No Abstract]   [Full Text] [Related]  

  • 29. T cell recognition of cell-surface antigens. II. Antigen recognition is necessary yet not sufficient for triggering T cell-mediated immunity.
    Wekerle H; Kölsch E; Feldman M
    Eur J Immunol; 1974 Apr; 4(4):246-50. PubMed ID: 4212381
    [No Abstract]   [Full Text] [Related]  

  • 30. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sublethal irradiation on the plaque-forming cell response in mice.
    Schmidtke JR; Dixon FJ
    J Immunol; 1973 Sep; 111(3):691-7. PubMed ID: 4582261
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA; Leibowitz S
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The alternate complement pathway in cell damage: antibody-mediated cytolysis of erythrocytes and nucleated cells.
    May JE; Green I; Frank MM
    J Immunol; 1972 Sep; 109(3):595-601. PubMed ID: 4115545
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of hybrid cells in immunotherapy.
    Favre R; Carcassonne Y; Meyer G
    Oncology; 1977; 34(2):84-6. PubMed ID: 197461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the propagation of a B cell clone forming antibody to the 2,4-dinitrophenyl group.
    Askonas BA; Williamson AR
    Eur J Immunol; 1972 Dec; 2(6):487-93. PubMed ID: 4120275
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour induction in C3H and Swiss ICR mice by tissue culture preparations of polyoma virus.
    WALLACE R; JUNGHERR EL; MOYER AW
    Nature; 1963 Jan; 197():298-9. PubMed ID: 13998561
    [No Abstract]   [Full Text] [Related]  

  • 37. A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS.
    BLACK PH; ROWE WP; TURNER HC; HUEBNER RJ
    Proc Natl Acad Sci U S A; 1963 Dec; 50(6):1148-56. PubMed ID: 14096190
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of various forms of therapy in two different mouse tumor systems.
    Dullens HF; Vennegoor C; De Weger RA; Woutersen F; Woutersen RA; Den Otter W
    Cancer Treat Rep; 1979 Jan; 63(1):99-109. PubMed ID: 421238
    [No Abstract]   [Full Text] [Related]  

  • 39. Receptors for immune complexes on cells within a polyoma virus-induced murine sarcoma.
    Braslawsky GR; Serban D; Witz IP
    Eur J Immunol; 1976 Aug; 6(8):579-83. PubMed ID: 185060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of endogenous type-C virus in normal hamster tissues and hamster tumors induced by chemical carcinogens, simian virus 40, and polyoma virus.
    Freeman AE; Kelloff GJ; Vernon ML; Lane WT; Capps WI; Bumgarner SD; Turner HC; Huebner RJ
    J Natl Cancer Inst; 1974 May; 52(5):1469-76. PubMed ID: 4364732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.